Simmons Jeffrey N 4
4 · Elanco Animal Health Inc · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
Elanco CEO Jeffrey Simmons Receives Award of 118 Deferred Shares
What Happened
Jeffrey N. Simmons, President, CEO and Director of Elanco Animal Health Inc. (ELAN), received a grant of 117.887 deferred stock units on 2026-03-20. The units were recorded at $23.98 each, totaling about $2,827. The transaction is coded as an award/grant (A) and is a derivative award rather than an open-market purchase.
Key Details
- Transaction date: 2026-03-20; filing date: 2026-03-24 (filed within the two-business-day Form 4 window).
- Price reported: $23.98 per unit; total reported value: ~$2,827.
- Security type: Deferred stock units (derivative). Transaction code: A (award/grant).
- Shares owned after transaction: not specified in the provided filing details.
- Footnotes: F1—each deferred stock unit equals the right to one share or the cash equivalent; F2—units settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
Context
Deferred stock units are a form of executive compensation that convert to shares or cash at a later date and do not reflect an immediate market purchase or sale. This grant is routine compensation-related activity (modest in dollar value) and should be interpreted differently than open-market buys or sales.
Insider Transaction Report
- Award
Deferred Stock Units
[F1][F2]2026-03-20$23.98/sh+117.887$2,827→ 23,795.27 total→ Common Stock (117.887 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- [F2]Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.